Dataset Information


Feasibility of repairing glomerular basement membrane defects in Alport syndrome.

ABSTRACT: Alport syndrome is a hereditary glomerular disease that leads to kidney failure. It is caused by mutations affecting one of three chains of the collagen ?3?4?5(IV) heterotrimer, which forms the major collagen IV network of the glomerular basement membrane (GBM). In the absence of the ?3?4?5(IV) network, the ?1?1?2(IV) network substitutes, but it is insufficient to maintain normal kidney function. Inhibition of angiotensin-converting enzyme slows progression to kidney failure in patients with Alport syndrome but is not a cure. Restoration of the normal collagen ?3?4?5(IV) network in the GBM, by either cell- or gene-based therapy, is an attractive and logical approach toward a cure, but whether or not the abnormal GBM can be repaired once it has formed and is functioning is unknown. Using a mouse model of Alport syndrome and an inducible transgene system, we found that secretion of ?3?4?5(IV) heterotrimers by podocytes into a preformed, abnormal, filtering Alport GBM is effective at restoring the missing collagen IV network, slowing kidney disease progression, and extending life span. This proof-of-principle study demonstrates the plasticity of the mature GBM and validates the pursuit of therapeutic approaches aimed at normalizing the GBM to prolong kidney function.

PROVIDER: S-EPMC3968506 | BioStudies | 2014-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4182137 | BioStudies
2003-01-01 | S-EPMC1868284 | BioStudies
| S-EPMC1464339 | BioStudies
2018-01-01 | S-EPMC6146048 | BioStudies
2012-01-01 | S-EPMC3517557 | BioStudies
1000-01-01 | S-EPMC2827946 | BioStudies
2016-01-01 | S-EPMC5154607 | BioStudies
2020-01-01 | S-EPMC7642296 | BioStudies
2018-01-01 | S-EPMC5827610 | BioStudies
1000-01-01 | S-EPMC3790497 | BioStudies